3 Drugs That Could Make-or-Break AbbVie Post author:Sam Post published:February 11, 2018 Post category:BioPharma A look at three drug approvals of vital importance to the company this year. Source: BioSpace You Might Also Like 2 Biotechs That Had a Rough 2016 But May Be Poised for a Turnaround This Year February 22, 2017 Former Celator CPA Connived With Two Friends, Father on Insider-Trading Scheme August 31, 2017 Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi July 19, 2017
